Albert Marcano
Primary Care · Jackson Heights, NYNPI 1861572562
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 462 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Among primary care clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 462 payments — averaging $33.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- AstraZeneca$2K
- Bayer$1K
- Novo Nordisk$1K
- Amgen$1K
- Esperion Therapeutics, Inc.$633
- plus $5K from 31 others
What the payments were for
- Food & beverage$15,320100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 89 | $3,283 |
| AstraZeneca | 40 | $2,069 |
| Bayer | 44 | $1,424 |
| Novo Nordisk | 46 | $1,284 |
| Amgen(2 entities) | 38 | $1,170 |
| Esperion Therapeutics, Inc. | 15 | $633 |
| Merck | 25 | $563 |
| Pfizer | 26 | $545 |
| Boehringer Ingelheim | 14 | $508 |
| Lilly USA, LLC | 15 | $454 |
| Sumitomo Pharma America, Inc. | 11 | $280 |
| Ardelyx, Inc. | 10 | $279 |
| Amarin Pharma, Inc. | 14 | $274 |
| Ironwood Pharmaceuticals, Inc | 6 | $259 |
| Phathom Pharmaceuticals, Inc. | 3 | $191 |
| Axsome Therapeutics, Inc. | 4 | $176 |
| Lundbeck LLC | 4 | $169 |
| Johnson & Johnson | 2 | $167 |
| Medtronic | 1 | $157 |
| Sunovion Pharmaceuticals Inc. | 10 | $152 |
| E.r. Squibb & Sons, L.L.C. | 6 | $145 |
| Astellas Pharma US Inc | 5 | $139 |
| Zimmer Biomet | 3 | $131 |
| Gilead | 1 | $125 |
| Novartis | 6 | $124 |
| Intuity Medical Inc | 1 | $114 |
| Amryt Pharma Holdings Ltd | 1 | $100 |
| Redhill Biopharma Inc. | 4 | $94 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $93 |
| Vistapharm, Inc. | 3 | $43 |
| Intra-sana Laboratories | 2 | $35 |
| GSK | 2 | $34 |
| Vertex | 1 | $31 |
| Cequr Corporation | 1 | $26 |
| Advanced Oxygen Therapy Inc. | 1 | $23 |
| Incyte Corporation | 1 | $23 |
| Corium, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,333 in reported general payments places this provider in the 95th percentile of 239 primary care providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 76 | $81,151 |
| Diclofenac Potassium | 29 | $68,437 |
| TrulicityDulaglutide | 44 | $62,695 |
| OzempicSemaglutide | 43 | $50,441 |
| KerendiaFinerenone | 41 | $46,992 |
| FarxigaDapagliflozin Propanediol | 34 | $40,406 |
| XareltoRivaroxaban | 35 | $31,498 |
| JanumetSitagliptin Phos/Metformin Hcl | 28 | $30,436 |
| JanuviaSitagliptin Phosphate | 29 | $26,893 |
| ProliaDenosumab | 15 | $24,334 |
| EliquisApixaban | 25 | $24,132 |
| Diclofenac Sodium | 194 | $23,405 |
| VascepaIcosapent Ethyl | 40 | $16,435 |
| TradjentaLinagliptin | 14 | $16,211 |
| LinzessLinaclotide | 20 | $14,494 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $508 | $97,36190 claims |
| Lilly USA, LLCTrulicity | $454 | $62,69544 claims |
| MerckJanumet, Januvia | $563 | $57,32957 claims |
| Novo NordiskOzempic | $1,284 | $50,44143 claims |
| BayerKerendia | $1,424 | $46,99241 claims |
| AstraZenecaFarxiga | $2,069 | $40,40634 claims |
| Johnson & JohnsonXarelto | $167 | $31,49835 claims |
| AbbVieLinzess, Qulipta | $3,283 | $27,78733 claims |
| AmgenProlia | $1,170 | $24,33415 claims |
| PfizerEliquis | $545 | $24,13225 claims |
| GSKShingrix | $34 | $10,63856 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 239 primary care providers in New York.
Other primary care in Jackson Heights
- Dorothy KleinertNew York$27K
- Stephanie KhanForest Hills$16K
- Elizabeth GattmanJamestown$10K
- Vanessa WangFlushing$10K
- Elizabeth SmithWaterloo$9K
- Eric RodriguezSyracuse$7K
- Natalie Sommerville-BrooksBrooklyn$6K
- Lisa PlanetaNew York$6K
- Pao-Ju TsengFlushing$6K
- Eliezer HernandezAlbany$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.